Narcolepsy
RecruitingEfficacy and Safety of ALKS 2680 and Alixorexton in Adults with Narcolepsy Type 1
- Disease:Narcolepsy
- Substances:Alks 2680
Italy- Participants:18–64 years · 65+ years
- Substances:Alks 2680
- Sponsor:Alkermes Inc.
Rare diseases
Investigational molecules
Locations
Back to Italy420 clinical trials in Verona, Italy across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on acute ischemic stroke treatment and neurological conditions including narcolepsy and Dravet Syndrome. Studies evaluate new therapeutic approaches for improving patient outcomes and managing symptoms.
Multiple trials exploring novel medications and treatment combinations for better patient care.
Comprehensive studies targeting various cancers including gastric cancer, Merkel cell carcinoma, and metastatic colorectal cancer. Research focuses on innovative treatment combinations and targeted therapies.
Trials investigating novel drug combinations and personalized treatment strategies.
Clinical investigations into Sjögren's Syndrome, systemic sclerosis, and other autoimmune disorders. Studies evaluate new biological treatments and their long-term effectiveness.
Research focusing on improving quality of life and disease management for patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.